SPG21 Gene

SPG21 — Spastic Paraplegia 21 (Maspardin)

Overview

SPG21 (Spastic Paraplegia 21), also known as maspardin (Mast syndrome protein) or ACP33 (Acidic Cluster Protein 33), is a gene that encodes a crucial protein involved in endosomal trafficking, autophagy, and synaptic vesicle dynamics. Located on chromosome 15q22.31, SPG21 mutations cause an autosomal recessive form of hereditary spastic paraplegia (HSP) characterized by progressive lower limb spasticity, with some patients developing dementia—a condition termed "Mast syndrome"[@martinez2019].

SPG21 — Spastic Paraplegia 21 (Maspardin)

Overview

SPG21 (Spastic Paraplegia 21), also known as maspardin (Mast syndrome protein) or ACP33 (Acidic Cluster Protein 33), is a gene that encodes a crucial protein involved in endosomal trafficking, autophagy, and synaptic vesicle dynamics. Located on chromosome 15q22.31, SPG21 mutations cause an autosomal recessive form of hereditary spastic paraplegia (HSP) characterized by progressive lower limb spasticity, with some patients developing dementia—a condition termed "Mast syndrome"[@martinez2019].

The SPG21/maspardin protein is a member of the alpha/beta hydrolase fold family and localizes primarily to the cytosol and endosomal compartments. It functions as an accessory protein within the ESCRT (Endosomal Sorting Complex Required for Transport) machinery, playing essential roles in cargo sorting, membrane remodeling, and the formation of multivesicular bodies. These functions are critical for neuronal protein homeostasis, as neurons are particularly dependent on efficient endolysosomal pathways for clearing misfolded proteins and maintaining synaptic function["@martinez2020"].

Recent research has expanded our understanding of SPG21 beyond its role in HSP to include broader implications in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The protein's involvement in autophagy, lysosomal function, and mitochondrial quality control positions it as an important player in cellular proteostasis mechanisms relevant to many neurodegenerative diseases["@alvarez2019"].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SPG21 — Maspardin (Mast Syndrome Protein)</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SPG21 (ACP33)</td></tr>
<tr><td><strong>Full Name</strong></td><td>Spastic Paraplegia 21 / Maspardin</td></tr>
<tr><td><strong>Chromosome</strong></td><td>15q22.31</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[80031](https://www.ncbi.nlm.nih.gov/gene/80031)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[607111](https://omim.org/entry/607111)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000046753</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BRK0](https://www.uniprot.org/uniprot/Q9BRK0)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Alpha/beta hydrolase fold family</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytosol, endosomes</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Hereditary Spastic Paraplegia, Mast Syndrome</td></tr>
</table>
</div>

Gene Structure and Evolution

Genomic Organization

The SPG21 gene is located on the long arm of chromosome 15 (15q22.31), spanning approximately 12 kb of genomic DNA. The gene consists of 11 exons that encode a protein of 311 amino acids with a molecular weight of approximately 35 kDa.

The genomic region containing SPG21 shows moderate evolutionary conservation, with orthologs identified in mammals, birds, and reptiles. The protein contains an alpha/beta hydrolase fold domain that is conserved across species, reflecting the fundamental importance of this structural motif in cellular function.

Splice Variants

Multiple transcript variants of SPG21 have been described:

• Variant 1 (canonical): Full-length protein (311 amino acids)
• Variant 2: Alternative splicing in 5' UTR affecting translation efficiency
• Variant 3: Truncated isoform with possible dominant-negative function

Protein Structure and Function

Domain Architecture

Maspardin possesses several functional domains essential for its role in endosomal trafficking:

The alpha/beta hydrolase fold in maspardin is structural rather than enzymatic—the protein lacks catalytic activity but provides a scaffold for protein-protein interactions. This fold is common among proteins involved in diverse cellular processes, including metabolism, signaling, and trafficking.

Role in ESCRT Machinery

Maspardin functions as an accessory protein within the ESCRT (Endosomal Sorting Complex Required for Transport) system[@tommasini2023]:

The ESCRT machinery is composed of four distinct complexes (ESCRT-0, -I, -II, and -III) that work sequentially to sort cargo into forming multivesicular bodies. Maspardin associates with ESCRT-III components and facilitates their function in membrane scission events.

Key Substrates and Partners

Maspardin interacts with several cellular proteins:

| Partner | Function | Disease Relevance |
|---------|----------|-------------------|
| CHMP4B | ESCRT-III component | Multivesicular body formation |
| VPS4 | AAA ATPase | Membrane remodeling |
| IST1 | ESCRT-III associated | cytokinesis, neuron function |
| CHMP1A | ESCRT-III component | Lysosomal trafficking |
| TDP-43 | RNA-binding protein | ALS/FTD proteinopathy |

Role in Endosomal Trafficking

Endolysosomal Pathway Overview

The endolysosomal pathway is crucial for cellular protein homeostasis:

Maspardin functions primarily at the level of late endosomes, where it participates in cargo sorting and the formation of multivesicular bodies (MVBs)[@zhang2024].

Maspardin in MVB Formation

Maspardin contributes to MVB formation through several mechanisms:

• Cargo selection: Recognizes ubiquitinated membrane proteins
• ESCRT recruitment: Recruits ESCRT-III components to endosomal membranes
• Membrane remodeling: Facilitates invagination of the limiting membrane
• Vesicle scission: Assists in release of intralumenal vesicles

Retromer Association

Maspardin also interacts with the retromer complex, a key player in endosomal protein sorting[@park2019]:

• VPS35: Core retromer subunit
• VPS26: Retrieval receptor component
• VPS29: Retromer accessory protein

Autophagy and Lysosomal Function

Maspardin in Autophagy

Maspardin plays important roles in autophagy, the cellular degradation pathway[@chang2021]:

Lysosomal Function

Maspardin supports lysosomal function through multiple pathways:

• Lysosomal enzyme trafficking: Participates in delivery of hydrolases
• Membrane maintenance: Supports lysosomal membrane integrity
• Autophagy-lysosome pathway: Critical for protein aggregate clearance
• Calcium homeostasis: Regulates lysosomal calcium release

Lysosomal Dysfunction in SPG21 Deficiency

Loss of maspardin function leads to lysosomal abnormalities[@wang2023]:

• Enzyme trafficking defects: Impaired delivery of cathepsins
• Accumulation of undegraded material: Lipofuscin-like deposits
• Altered lysosomal pH: Impaired hydrolase activity
• Autophagic flux blockade: Failure to clear protein aggregates

Disease Associations

Hereditary Spastic Paraplegia (SPG21)

SPG21 mutations cause an autosomal recessive form of HSP with the following characteristics[@ye2018]:

Clinical Features:

• Progressive lower limb spasticity (spastic paraplegia)
• Onset typically in adulthood (third to fourth decade)
• Variable presence of dementia
• Thin corpus callosum on MRI
• No peripheral neuropathy (distinguishing from SPG15)
• Cognitive decline in some patients (Mast syndrome)

• Loss of maspardin function leads to endosomal trafficking defects
• Impaired lysosomal function causes protein accumulation
• Autophagy failure results in aggregate formation
• Synaptic dysfunction contributes to cognitive decline
• Axonal degeneration due to impaired axonal transport

Alzheimer's Disease

Maspardin dysfunction may contribute to Alzheimer's disease pathogenesis:

Parkinson's Disease

Connections between SPG21 and Parkinson's disease include:

Amyotrophic Lateral Sclerosis (ALS)

Maspardin may play a role in ALS through:

• TDP-43 trafficking: Altered endosomal sorting of TDP-43
• Protein aggregate clearance: Autophagy impairment
• Axonal transport: Synaptic vesicle trafficking deficits
• Mitochondrial dysfunction: Similar to other HSP-ALS genes

Mitochondrial Function

Maspardin and Mitochondrial Quality Control

Maspardin contributes to mitochondrial quality control through[@hernandez2022]:

SPG21 and Mitochondrial Dysfunction

SPG21 deficiency leads to mitochondrial abnormalities:

• Respiratory chain defects: Reduced Complex I activity
• Mitochondrial membrane potential: Loss of membrane integrity
• Calcium handling: Impaired mitochondrial calcium buffering
• ROS production: Increased oxidative stress
• Axonal degeneration: Energy deficit in long axons

Neuroinflammation

Endosomal Dysfunction and Inflammation

Endosomal trafficking defects activate inflammatory pathways[@riviere2019]:

Inflammatory Markers in SPG21

Patients with SPG21 mutations show:

• Elevated CSF inflammatory markers
• Microglial activation on PET imaging
• Peripheral immune cell alterations
• Correlation with disease progression

Interaction Network

Protein-Protein Interactions

Maspardin interacts with numerous cellular proteins:

ESCRT Components:

• CHMP4B: ESCRT-III budding subunit
• CHMP1A: ESCRT-III accessory factor
• IST1: ESCRT-III associated protein
• VPS4: AAA ATPase for ESCRT disassembly

• VPS35: Core retromer subunit
• VPS26: Retromer coat component
• VPS29: Retromer accessory protein

• TDP-43: ALS/FTD proteinopathy protein
• Alpha-synuclein: PD protein aggregation
• APP: Amyloid precursor protein

Signaling Pathway Integration

Maspardin integrates with several key pathways:

• mTOR pathway: Autophagy regulation
• ER stress response: UPR signaling
• Apoptosis pathway: Regulation of cell death
• Cytoskeletal dynamics: Axonal transport

Therapeutic Implications

Small Molecule Approaches

Targeting SPG21-related pathways for therapeutic benefit[@gomez2021]:

Gene Therapy Approaches

AAV-mediated SPG21 modulation:

• Gene replacement: Deliver functional SPG21
• Optimized variants: Engineer enhanced activity
• Cell-type specificity: Target specific neuronal populations

Combination Therapies

Maspardin modulators may synergize with:

• Proteostasis enhancers: Broader protein clearance
• Antioxidants: Reduce oxidative stress
• Neurotrophic factors: Support neuronal survival
• Immunomodulators: Address inflammation

Animal Models

Knockout Mouse

Sp21 knockout mice show phenotypes relevant to HSP:

• Motor deficits: Reduced rotarod performance
• Endosomal abnormalities: Electron microscopy findings
• Protein accumulation: Ubiquitin-positive aggregates
• Axonal degeneration: Reduced axon caliber

Zebrafish Model

Zebrafish spg21 mutants show:

• Developmental abnormalities
• Motor behavior deficits
• Endosomal trafficking defects
• Useful for drug screening

Drosophila melanogaster

Drosophila models demonstrate:

• Synaptic transmission defects
• Photoreceptor degeneration
• Lifespan reduction
• Genetic interaction studies

Research Directions

Current Questions

Key research areas for SPG21 in neurodegeneration:

Emerging Approaches

• Single-cell analysis: Cell-type specific maspardin functions
• Proteomics: Identify maspardin substrate networks
• CRISPR screening: Synthetic lethal partner identification
• iPSC models: Patient-derived neuronal models

Cross-Links

SPG21 connects to multiple NeuroWiki pages:

• [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
• [Endolysosomal Pathway](/mechanisms/endolysosomal-trafficking)
• [ESCRT Machinery](/mechanisms/esCRT-machinery)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-neurodegeneration)
• [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction)
• [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
• [Protein Ubiquitination](/mechanisms/protein-ubiquitination)
• [Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SPG21 Gene discovered through SciDEX knowledge graph analysis: